We are proud to share an exciting outcome that highlights exceptional engagement efforts linking collaborative Institute for Biomedicine and Glycomics research expertise and initiatives with industry and the broader community. A Griffith Office of Advancement team and the Spinal Injury Project team within the Clem Jones Centre for Neurobiology and Stem Cell Research have received a Highly Commended in the Award for Excellence in Industry and Community Engagement category of the Association for Tertiary Education Management (ATEM) 2024 Awards for Excellence! The award submission spoke to the partnership role that the Advancement team and the Spinal Injury Project team built with key stakeholders – the Perry Cross Spinal Research Foundation, the Clem Jones Foundation, the Motor Accident Insurance Commission (MAIC) and the spinal injury community which greatly accelerated fundraising targets, enabling the project to commence a world-first clinical trial. Congratulations to everyone involved, this recognition reflects outstanding commitment and dedication to excellence in engagement which not only strengthens our connections with the community but also creates significant benefits and positive impact for both our partners and Griffith University. More information on Griffith University’s world-first clinical trial for treating spinal cord injury can be found here: https://lnkd.in/gT2GRmtp #CommunityEngagement #ResearchExcellence #TeamSuccess Research at Griffith Gold Coast Health and Knowledge Precinct
Griffith University Institute for Biomedicine and Glycomics
Research Services
Southport, Queensland 4,848 followers
About us
The Institute for Biomedicine and Glycomics has combined the expertise of its founding institutes — the Institute for Glycomics, Griffith Institute for Drug Discovery, and the biomedical teams from within the Menzies Health Institute Queensland. Each of the three founding institutes have strong reputations for research excellence in their own right, together they will be formidable. Griffith biomedical researchers lead the world in specific disciplinary areas, and work on challenges that affect communities around the world including some of the poorest and most disenfranchised. By investing in this new Institute for Biomedicine and Glycomics, we position ourselves to support our world-leading teams to achieve even greater successes.
- Website
-
https://www.griffith.edu.au/institute-biomedicine-glycomics
External link for Griffith University Institute for Biomedicine and Glycomics
- Industry
- Research Services
- Company size
- 201-500 employees
- Headquarters
- Southport, Queensland
- Type
- Nonprofit
- Specialties
- drug discovery, infectious diseases, cancer, Parkinson's disease, spinal cord injury, community engagment, training postgraduate students, pre-clinical studies, chemistry, biology, antimicrobial resistance, natural product chemistry, Saliva diagnostics, platform technologies, industry engagement, research translation and commercialisation, neuropathologies, and research impact
Locations
-
Primary
Get directions
1 Parklands Dr
Southport, Queensland 4215, AU
-
Get directions
Don Young Rd
Nathan, Queensland 4111, AU
Employees at Griffith University Institute for Biomedicine and Glycomics
Updates
-
We are thrilled to share that Institute for Biomedicine and Glycomics researchers Professor Katherine Andrews, Professor Daniel Kolarich, Associate Professor Thomas Ve and Dr Santosh Rudrawar, along with collaborators on Griffith University led projects, have been successful in the Australian Research Council’s latest round of Discovery Projects. Congratulations to all the successful Griffith University researchers! https://lnkd.in/ggJ-xsry
-
Congratulations to Institute for Biomedicine and Glycomics Principal Research Leader Professor Michael Jennings who has been named an Australian research field leader in the Australian newspaper's annual Research Magazine (2025). The 2025 Research Magazine celebrates the excellence of Australian research by delving deep into the data and identifying the top researcher in 250 fields of research. Professor Jennings was named the top researcher in the field of Biochemistry, within the discipline of Chemical and Material Sciences, for the third year running, based on the number of citations for papers published in the top 20 journals in the field over the past five years.
-
-
Join us this Friday 29 November at 11am for a seminar presented by guest speaker Professor Katja Kanninen, Cellular Neurobiology Research Group A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Finland. “From nose to brain: biological effects of air pollution ultrafine particles” The seminar will be held in the Ron Quinn Seminar Room at the Institute for Biomedicine and Glycomics, Griffith University, Nathan campus (Building N75).
-
-
Congratulations to Institute for Biomedicine and Glycomics Research Leader Dr Frank Sainsbury who has been promoted to Associate Professor and Early Career Research Leader Dr Victoria Ozberk who has been promoted to Research Fellow Grade 2 in the Griffith University 2024 Academic Promotion Round!
-
-
Congratulations to Institute for Biomedicine and Glycomics Research Leader Dr Jean Giacomotto who has been awarded a Metro South Health Research Grant with clinicians Dr Korinne Northwood, Professor Dan Siskind and Griffith Health Professor Amanda J Wheeler as well as University of Otago. Their research aims to better understand and mitigate clozapine side effects using zebrafish. Dr Giacomotto also welcomes PhD student Mr Oon Linus to the team who will be working on the project.
-
-
Congratulations to Institute for Biomedicine and Glycomics Research Leader, Associate Professor Rohan A. Davis and IBG Associate, Professor Anthony (Tony) Carroll who were recently identified as Highly Cited researchers by Clarivate (Web of Science) in their annual analysis of research outputs. Each year Clarivate identifies the small fraction of the global research scientists and social scientists who have demonstrated significance and broad influence in their field(s) of research. Research at Griffith
-
-
Institute for Biomedicine and Glycomics PhD Candidate Alex Johnston recently completed a 3-month internship at Sanofi Translational Science Hub (TSH) and shares her insights about this inspiring and rewarding experience. Research at Griffith
Meet Griffith University PhD Candidate Alex Johnston! Undertaking her research at the Laboratory of Vaccines for the Developing World within the Griffith University Institute for Biomedicine and Glycomics, Alex’s research focuses on the optimisation and translation of a novel whole-parasite malaria vaccine candidate through preclinical studies, development of a potency assay, and immunogenicity analysis in an upcoming Phase 1 Clinical Trial. Alex recently completed a 3-month internship at Sanofi Translational Science Hub (TSH) and has shared her experience below. “My internship was a fabulous opportunity to test out my future career pathway in Clinical Trials and I discovered this was a great fit for me. I found my internship work to be both inspiring and rewarding. My internship has further sparked my passion for Clinical Trial research and making the world a better place. I was motivated to undertake an internship to develop my understanding of Clinical Trial research and gain real-world industry experience. I leveraged my skills in vaccine research to adapt to this fast-paced industry role and was able to expand both my knowledge of vaccine therapeutics and capabilities as a PhD candidate.” “I supported multiple projects that progressed financial, logistical and ethical requirements across three early-phase TSH Clinical Trials investigating diseases and novel vaccine candidates. During this amazing opportunity, I streamlined and updated current operational procedures, and I designed a new budget negotiation tool that has since been adopted by Sanofi. I also focused on the initiation of a charitable donation program, assessed strategies to create participant-centric trials and communicated numerous key research outputs.” “It was so beneficial as it provided me with valuable connections within the industry and the broader Clinical Trial network across vendors, Contract Research Organizations (CROs) and Clinical Trial sites. My highlights included attending a Human Research Ethics Committee (HREC) Workshop hosted by Bellberry on Clinical Trial protocol development and ethics submissions that is relevant to my PhD candidature. I also had the privilege of meeting the French Ambassador during his tour of Sanofi TSH.” Alex also shared her thoughts below on why PhD candidates should consider internship experiences during their candidature. “Internships are vital for PhD candidates to gain stakeholder engagement experience, networking opportunities and establish industry connections. I recommend that every HDR candidate undertake an internship placement as it will not only provide you the opportunity to represent Griffith University but also broaden your horizons. You will gain valuable workplace experiences and learn about diverse research projects which will enhance your knowledge and employability.” Pictured (left to right): (late) Dr Iris Depaz, Naga Bandari, Alex Johnston, Dr Saranya Sridhar
-
-
The Spinal Cord Injury Clinical Trial has received a philanthropic gift of a $100,000 donation from Terry and Rhonda White. Read more about the White Family’s generous support, the Phase I human clinical trial and the research being led by Health Group and IBG Principal Research Leader Professor James St John and the Spinal Injury Project team within the Clem Jones Centre for Neurobiology and Stem Cell Research in this Griffith News Story: https://lnkd.in/gb6-yCPD
Funding gift for spinal injury clinical trial - Griffith News
https://news.griffith.edu.au
-
We are delighted to announce Professor Paul R Clarke has officially commenced his role as Executive Director of Griffith University’s Institute for Biomedicine and Glycomics. Professor Clarke brings a wealth of experience as both a leader and internationally recognised biomedical researcher who has worked at the translational interface between medicine and biology for more than 25 years. This is an exciting era for biomedicine at Griffith University and for the biomedical industry across South-East Queensland as we establish a reputation as a globally competitive biomedical industry hub recognised for its excellence in biomedical innovation, highly skilled workforce and world-leading translational biomedical research facilities. We have a proud history of research excellence and translational successes. We look forward to forging a transformative new chapter for biomedical research at Griffith University under Professor Clarke’s leadership.
-